株式会社極東書店トップ ＞ 商品一覧 ＞ Pharmaceutical Industry Practices on Genotoxic Impurities.
商品詳細
Pharmaceutical Industry Practices on Genotoxic Impurities.
・ISBN 978-1-4398-7420-2 hard GB£ 210.00
￥66,528.- (税込) ※（※）価格はご注文時の参考価格となります。
納品価格につきましては書籍の入荷時点で確定となります。
版元の原価改定、外国為替の変動等により異なる場合がございますので、予めご了承下さい。
| 著者・編者 | Lee, Heewon (ed.), |
|---|---|
| シリーズ | (Chromatographic Science Series) |
| 出版社 | (CRC Press Inc, US) |
| 出版年月 | 2014 |
| ページ数 | 536 pp. |
| 言語 | ENG |
| ニュース番号 | ＜A00-51995＞ |
解説
A great deal of confusion and uncertainty over genotoxic impurity (GTI) identification, assessment, and control exists in the pharmaceutical industry today. Pharmaceutical Industry Practices on Genotoxic Impurities strives to facilitate scientific and systematic consensus on GTI management by presenting rationales, strategies, methods, interpretations, practices, and case studies from the pharmaceutical industry. Featuring the contributions of industry leaders from nine major pharmaceutical companies, this authoritative text:
- Explores the safety, quality, and regulatory aspects of GTIs
- Provides an overview of the latest FDA and EMEA guidelines
- Explains the how and why of various GTI control tactics and practices
- Describes genotoxicity evaluation, acceptable exposure calculation, and analytical methods for testing
- Includes real-life examples of GTI control in drug substance and drug product development processes
Containing case studies from large and small pharmaceutical firms in multiple geographical regions, Pharmaceutical Industry Practices on Genotoxic Impurities supplies an overview of-and a current framework for-GTI control in the pharmaceutical industry, demonstrating how proper management of GTIs can occur with the appropriate guidance, a firm grasp of the practical implications, and effective information sharing between disciplines.